Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01530 3SBIO
RTNominal down6.620 -0.050 (-0.750%)
Research Report

09/04/2021 14:11

{I-bank focus}Macquarie raises 3SBio (01530) to HK$13.08

[ET Net News Agency, 9 April 2021] Macquarie raised its target price for 3SBio (01530)
to HK$13.08 and maintained its "outperform" rating.
The research house said the market may need a bit more time to brush off the lacklustre
earnings in 2020 and negative impact of policy on 3SBio's current top products. However,
previous investments and R&D help bring an early-stage pipeline (interleukins and
bispecific) into the clinical stage. It believes this should excite investors again and
help re-rate the stock to its previous level and potentially more. (RC)

Remark: Real time quote last updated: 01/12/2021 17:17
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.